biote Corp. (BTMD)
BTMD Stock Price Chart
Explore biote Corp. interactive price chart. Choose custom timeframes to analyze BTMD price movements and trends.
BTMD Company Profile
Discover essential business fundamentals and corporate details for biote Corp. (BTMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
28 Apr 2021
Employees
223.00
Website
https://biote.comCEO
Robert C. Peterson
Description
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
BTMD Financial Timeline
Browse a chronological timeline of biote Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is $0.07, while revenue estimate is $46.12m.
Earnings released on 6 May 2026
EPS came in at $0.06 falling short of the estimated $0.09 by -33.33%, while revenue for the quarter reached $44.94m , missing expectations by -2.36%.
Earnings released on 11 Mar 2026
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $46.41m , beating expectations by +1.26%.
Earnings released on 5 Nov 2025
EPS came in at $0.22 surpassing the estimated $0.05 by +340.00%, while revenue for the quarter reached $47.96m , beating expectations by +4.73%.
Earnings released on 6 Aug 2025
EPS came in at $0.10 surpassing the estimated $0.06 by +66.67%, while revenue for the quarter reached $48.86m , beating expectations by +2.31%.
Earnings released on 7 May 2025
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $48.99m , beating expectations by +3.69%.
Earnings released on 12 Mar 2025
EPS came in at $0.10 surpassing the estimated $0.09 by +11.11%, while revenue for the quarter reached $49.83m , missing expectations by -6.81%.
Earnings released on 12 Nov 2024
EPS came in at $0.33 surpassing the estimated $0.09 by +266.67%, while revenue for the quarter reached $51.38m , beating expectations by +0.37%.
Earnings released on 8 Aug 2024
EPS came in at $0.14 surpassing the estimated $0.09 by +55.56%, while revenue for the quarter reached $49.17m , missing expectations by -4.30%.
Earnings released on 7 May 2024
EPS came in at $0.23 surpassing the estimated $0.05 by +360.00%, while revenue for the quarter reached $46.80m , beating expectations by +2.47%.
Earnings released on 12 Mar 2024
EPS came in at $0.18 surpassing the estimated $0.08 by +125.00%, while revenue for the quarter reached $45.70m , missing expectations by -0.23%.
Earnings released on 7 Nov 2023
EPS came in at -$0.11 falling short of the estimated $0.08 by -237.50%, while revenue for the quarter reached $45.56m , missing expectations by -4.90%.
Earnings released on 10 Aug 2023
EPS came in at $0.44 surpassing the estimated $0.10 by +340.00%, while revenue for the quarter reached $49.26m , beating expectations by +5.33%.
Earnings released on 9 May 2023
EPS came in at $0.94 surpassing the estimated $0.09 by +944.44%, while revenue for the quarter reached $44.84m , beating expectations by +3.40%.
Earnings released on 28 Mar 2023
EPS came in at $0.18 surpassing the estimated $0.14 by +28.57%, while revenue for the quarter reached $44.49m , beating expectations by +1.49%.
Earnings released on 14 Nov 2022
EPS came in at -$0.09 falling short of the estimated $0.14 by -164.29%, while revenue for the quarter reached $41.97m , beating expectations by +0.01%.
Earnings released on 15 Aug 2022
EPS came in at $0.27 surpassing the estimated $0.14 by +92.86%, while revenue for the quarter reached $41.36m , beating expectations by +2.12%.
Earnings released on 21 May 2022
EPS came in at $1.23 , while revenue for the quarter reached $37.14m .
Earnings released on 7 Apr 2022
EPS came in at $0.72 , while revenue for the quarter reached $37.54m .
Earnings released on 24 Nov 2021
EPS came in at $1.13 , while revenue for the quarter reached $35.57m .
Earnings released on 17 Aug 2021
EPS came in at $1.29 , while revenue for the quarter reached $34.75m .
BTMD Stock Performance
Access detailed BTMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
